$3.955
-0.274 (-6.94%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
AN2 Therapeutics Inc (ANTX) Moving Averages Convergence Divergence (MACD) indicator is -0.14, suggesting ANTX is Sell.
AN2 Therapeutics Inc (ANTX) 20-Day simple moving average is 3.92, while AN2 Therapeutics Inc (ANTX) share price is $—, making it Buy.
AN2 Therapeutics Inc (ANTX) 60-Day simple moving average is 4.95, while AN2 Therapeutics Inc (ANTX) share price is $—, making it Sell.
Technical Analysis for ANTX
AI Technical ANTXAs of 2026-11-03, the technical board for AN2 Therapeutics Inc (ANTX) reads sell: 3 indicators are flashing buy, 6 are indicating sell, and 4 are neutral. Price at $3.95 sits below the 5-day, 10-day, 60-day and 200-day moving averages and above the 20-day.
Momentum readings: RSI stands at 42.989, MACD stands at -0.139 (Sell), Stochastic %K stands at 54.339, Stochastic %D stands at 61.374 and CCI stands at 13.066.
ANTX trades below the 60-day SMA (4.95) and below the 200-day SMA (4.13). Immediate resistance sits at Classic R1 4.88, then R2 5.60. Support sits at Classic S1 3.45, then S2 2.74.
AN2 Therapeutics Inc (ANTX) Support & Resistance Level
AN2 Therapeutics Inc (ANTX) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 42.989 |
| STOCHk_14_3_3 | 54.339 |
| STOCHd_14_3_3 | 61.374 |
| CCI_20 | 13.066 |
| AO_5_34 | -0.105 |
| MOM_10 | 0.315 |
| MACD_12_26_9 | -0.139 |
AN2 Therapeutics Inc (ANTX) Relative Strength Index (RSI_14) is 42.989, creating a Neutral signal.
AN2 Therapeutics Inc (ANTX) Stochastic %K is 54.339, creating a Neutral signal.
AN2 Therapeutics Inc (ANTX) Stochastic %D is 61.374, creating a Neutral signal.
AN2 Therapeutics Inc (ANTX) CCI_20 is 13.066, creating a Neutral signal.
AN2 Therapeutics Inc (ANTX) Awesome Oscillator (AO) is -0.105, creating a Sell signal.
AN2 Therapeutics Inc (ANTX) Momentum (MOM) is 0.315, creating a Buy signal.
AN2 Therapeutics Inc (ANTX) Moving Average Convergence Divergence (MACD) is -0.139, creating a Sell signal.
AN2 Therapeutics Inc (ANTX) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 4.253 | Sell |
| MA_10 | 4.151 | Sell |
| MA_20 | 3.925 | Buy |
| MA_60 | 4.949 | Sell |
| MA_200 | 4.130 | Sell |
| MA_250 | 3.532 | Buy |
AN2 Therapeutics Inc (ANTX) 5-Day simple moving average is 4.253, while AN2 Therapeutics Inc (ANTX) share price is $, making it a Sell.
AN2 Therapeutics Inc (ANTX) 10-Day simple moving average is 4.151, while AN2 Therapeutics Inc (ANTX) share price is $, making it a Sell.
AN2 Therapeutics Inc (ANTX) 20-Day simple moving average is 3.925, while AN2 Therapeutics Inc (ANTX) share price is $, making it a Buy.
AN2 Therapeutics Inc (ANTX) 60-Day simple moving average is 4.949, while AN2 Therapeutics Inc (ANTX) share price is $, making it a Sell.
AN2 Therapeutics Inc (ANTX) 200-Day simple moving average is 4.130, while AN2 Therapeutics Inc (ANTX) share price is $, making it a Sell.
AN2 Therapeutics Inc (ANTX) 250-Day simple moving average is 3.532, while AN2 Therapeutics Inc (ANTX) share price is $, making it a Buy.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.